London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yep.......let sp calm down and positions you self better.
Well main because I'm not it lol........plus you had to pay full ask/right on resistance. Better op other time % wise.young bull ?.
Not really... no need to ramp/deramp this one it will do its own work. Its not a "fast buck" share. Will rise over next few trading days. Government funded too.. gl
Look at the buys now... Everyone wants in
What's the rush lol don't spoil it here lol,wait for sub 30p !!!!!.
Glad I found it :). GL to those in. Tried to buy no luck so cant be bothered. Looks good - may buy once settled.
35p but with only 15m shares this moves fast. It seems this one deal will secure them for the next 7 years... All the other contracts ..., kerching
Looks a safe bet which for aim is rare
yes its tempting... don't want to be spiked agin.
Yep so little shares on offer.other time for me.
On watchlist now... will do well but slow burner perhaps? Im ok - a bit fed up overall but hey... ce'st la rie.
Leave this go to sleep again and nab a better entry price,caught eye too.how you keep all good I trust.
Just needs volume to get this going... 50p year high price. Looks good. Any downsides to be seen? Early day I guess.
" Financial performance underpinned by strong revenue growth of 36% to £1.6m o Total income (revenue plus other income) up 40% to £2.0m o Loss reduced by 58% to £0.6m despite increased investment in R&D; Loss per share 4.1p (2014 loss per share 10.5p) o Cash of £1.95m at 31 March 2015 with second half cash inflows to include committed grant funding "
£4.5m mcap - this project alone £600k revenue per year + This long-term contract with a valued customer coupled with our other previously announced new wins provides strong foundations for our growing business."
Very nice! "IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, today announced that it has been awarded a long-term contract from a leading global pharmaceutical company with a revenue value to IXICO of c. $1 million per year. Quick research needed...
XICO sells technologies and services for the analysis of brain disease. We expect strong growth mainly driven by the expansion of its clinical trial business into new indications new markets and bigger contracts. It is also well placed to capitalise on the burgeoning use of digital technologies in disease management. Using DCF we value IXICO at £10.7m or 62p/share. More: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=117321#.VcSLF_lVhBd#ixzz3i7mzzlYi
I think investors are missing the inherent value of this company. Stock market value is appx £5.12 million, it has cash of appx £1.95 million. Taking out the cash element the business is valued valued at just £3.17 million This value does not reflect the enormous potential here - they are aiming to deliver the use of their diagnostic kit around the globe with major pharmaceutical companies, and are pretty much already firmly on the way to that. Compare the value of IXICO to other similar companies and you will see a multiples of IXCO's value THE SHARE WLL NOT REMAIN AT THIS LEVEL FOR LONG
Forgot to mention that 40% increase is only from the Half Yearly Report to 31 March 2015. Their last years full revenue was around £4.4m